Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population-Reference-Cited by-同舟云学术

Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population

Published:2012-01-03 Issue:2 Volume:13 Page:197-204
ISSN:1470-269X
Container-title:The Pharmacogenomics Journal
language:en
Short-container-title:Pharmacogenomics J

Author:

Almoguera B, ,Riveiro-Alvarez R,Lopez-Castroman J,Dorado P,Vaquero-Lorenzo C,Fernandez-Piqueras J,Llerena A,Abad-Santos F,Baca-García E,Dal-Ré R,Ayuso C

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,Genetics,Molecular Medicine

Link

http://www.nature.com/articles/tpj201157.pdf

Reference51 articles.

1. Meyer UA . Pharmacogenetics - five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 2004; 5: 669–676.

2. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209–1223.

3. de Leon J, Sandson NB, Cozza KL . A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part I. Psychosomatics 2008; 49: 258–270.

4. Gasso P, Mas S, Bernardo M, Alvarez S, Parellada E, Lafuente A . A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. Pharmacogenomics J 2009; 9: 404–410.

5. Yasui-Furukori N, Mihara K, Takahata T, Suzuki A, Nakagami T, De Vries R et al. Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes. Br J Clin Pharmacol 2004; 57: 569–575.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of CYP2C19 and CYP2D6 on side effects of aripiprazole and risperidone: A systematic review;Journal of Psychiatric Research;2024-06

2. Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments;Pharmaceutics;2024-02-07

3. Developments in pharmacogenetics, pharmacogenomics, and personalized medicine;Pharmacological Research;2024-02

4. Pharmacogenomic Characterization in Bipolar Spectrum Disorders;Pharmaceutics;2019-12-21

5. Pharmacogenetic Correlates of Antipsychotic-Induced Weight Gain in the Chinese Population;Neuroscience Bulletin;2019-01-03